Latitude Pharmaceuticals Inc.
Records under this name other than the patents Latitude Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 8 of 8 · Back to Latitude Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,123,319 | Methods and Compositions for Treating Edema Refractory to Oral Diuretics Formerly held In force · High confidence | In force | High confidence | |
| US 11,260,038 | Methods and Compositions for Treating Edema Refractory to Oral Diuretics Formerly held In force · High confidence | In force | High confidence | |
| US 12,150,923 | Methods and Compositions for Treating Edema Refractory to Oral Diuretics Formerly held In force · High confidence | In force | High confidence | |
| US 12,329,731 | Methods and Compositions for Treating Edema Refractory to Oral Diuretics Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,968,621 | Parenteral compositions of celecoxib Lapsed on the fee record Ended May 15, 2026 · USPTO record | Lapsed on the fee record | Ended May 15, 2026 | USPTO record |
| US 8,557,861 | Low oil emulsion compositions for delivering taxoids and other insoluble drugs Lapsed on the fee record Ended Oct 15, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 15, 2025 | USPTO record |
| US 8,470,346 | Anti-viral pharmaceutical compositions Term ended Ended no later than Dec 3, 2024 · USPTO record | Term ended | Ended no later than Dec 3, 2024 | USPTO record |
| US 9,446,056 | Parenteral compositions of celecoxib Lapsed on the fee record Ended Sep 20, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 20, 2020 | USPTO record |